Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Application of the 'Spiking' method to the measurement of low dose radiation (≤ 1Gy) using alanine dosimeters

Geso M, Ackerly T, Lim SA, Best SP, Gagliardi F, Smith CL

(2018), Appl Radiat Isot, 133, 111-116

DOI: 10.1016/j.apradiso.2018.01.003

Dose response and stability of water equivalent PRESAGE® dosimeters for synchrotron radiation therapy dosimetry

Gagliardi FM, Franich RD, Geso M

(2018), Phys Med Biol, 63(23), 235027

DOI: 10.1088/1361-6560/aaf1f5

Water equivalent PRESAGE® for synchrotron radiation therapy dosimetry

Gagliardi FM, Day L, Poole CM, Franich RD, Geso M

(2018), Med Phys, 45(3), 1255

DOI: 10.1002/mp.12745

Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination

Evans SM, Murphy DG, Davis ID, Sengupta S, Borzeshi EZ, Sampurno F, Millar JL

(2018), Asia Pac J Clin Oncol, 14(5), e412-19

DOI: 10.1111/ajco.12875

Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria

Evans MA, Millar JL, Earnest A, Frydenberg M, Davis ID, Murphy DG, Kearns PA, Evans SM

(2018), Med J Aust, 208(10), 439-443

DOI: 10.5694/mja17.00559

Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update

Wang LL, Begashaw K, Evans M, Earnest A, Evans SM, Millar JL, Murphy DG, Moon D

(2018), ANZ J Surg, 88(10), 1037-1042

DOI: 10.1111/ans.14722

Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer

Collins A, Sundararajan V, Burchell J, Millar J, McLachlan SA, Krishnasamy M, Le BH, Mileshkin L, Hudson P, Philip J

(2018), J Pain Symptom Manage, 56(2), 185-194

DOI: 10.1016/j.jpainsymman.2018.03.022

Missing Evidence: Exploring Unpublished Trials in Victoria, Australia

Allan C, Chapman A, Parker C, Boltong A, Millar J

(2018), J Global Onc, Supplement 2, 96

DOI: 10.1200/jgo.18.28700

High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy

Chandrasekara S, Davis S, Thomson P, Haydon A

(2018), Asia Pac J Clin Oncol, 14(5), e442-7

DOI: 10.1111/ajco.12846

Preclinical radiotherapy at the Australian Synchrotron's Imaging and Medical Beamline: instrumentation, dosimetry and a small-animal feasibility study

Livingstone J, Adam JF, Crosbie JC, Hall CJ, Lye JE, McKinlay J, Pelliccia D, Pouzoulet F, Prezado Y, Stevenson AW, Hâusermann D

(2017), J Synchrotron Radiat, 24(Pt 4), 854-65

DOI: 10.1107/S1600577517006233

Environmental tobacco smoke and peripheral arterial disease: a review

Ngu NL, McEvoy M

(2017), Atherosclerosis, 266, 113-20

DOI: 10.1016/j.atherosclerosis.2017.09.024

Investigation of IRGANOX® 1076 as a dosimeter for clinical X-ray, electron and proton beams and its EPR angular response

Smith C, Ankers E, Best S, Gagliardi F, Katahira K, Tsunei Y, Takahiro T, Geso M

(2017), Rad Phys Chem, 141, 284-91

DOI: 10.1016/j.radphyschem.2017.08.002

Real-time in-vivo dosimetry

Beaulieu L, Franich RD, Smith RL

(2017), In: Song WY, Tanderup K, Pieters B (eds), Emerging Technologies in Brachytherapy, CRC Press, Chapter 9,

Stereotactic ablative body radiotherapy for the treatment of spinal oligometastases

Chang JH, Gandhidasan S, Finnigan R, Whalley D, Nair R, Herschtal A, Eade T, Kneebone A, Ruben J, Foote M, Siva S

(2017), Clin Oncol, 29(7), e119-e25

DOI: 10.1016/j.clon.2017.02.004

Long-term survivors of glioblastoma: a closer look

Gately L, McLachlan S, Philip J, Ruben J, Dowling A

(2017), J Neurooncol, 136(1), 155-62

DOI: 10.1007/s11060-017-2635-1

The effects of gold nanoparticles concentrations and beam quality/LET on dose enhancement when irradiated with X-rays and protons using alanine/EPR dosimetry

Smith CL, Best SP, Gagliardi F, Tominaga T, Geso M

(2017), Radiat Meas, 106, 352-6

DOI: 10.1016/j.radmeas.2017.01.019

A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192 Ir brachytherapy

Ma Y, Vijande J, Ballester F, Tedgren ?C, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L

(2017), Med Phys, 44(11), 5961-76

DOI: 10.1002/mp.12459

A randomized controlled trial of an additional funding intervention to improve clinical trial enrollment

Parker C, Snyder R, Jefford M, Dilts D, Wolfe R, Millar J

(2017), J Natl Compr Canc Netw, 15(9), 1104-10

DOI: 10.6004/jnccn.2017.0150

Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer

Ong WL, Foroudi F, Evans S, Millar JL

(2017), BJU Int, 120(Suppl 3), 35-42

DOI: 10.1111/bju.13969

3D catheter reconstruction in HDR prostate brachytherapy for pre-treatment verification using a flat panel detector

Smith RL, Haworth A, Panettieri V, Millar JL, Franich RD

(2017), Phys Med, 39, 121-31

DOI: 10.1016/j.ejmp.2017.06.008

5 6 7 8 9